Biotage AB Profile

USD 0.00  0.00%

Biotage AB Summary

Biotage AB (BITGF) is traded on OTC Market in USA. It is located in Box 8 and employs 397 people. The company currently falls under 'Small-Cap' category with current market capitalization of 869.11 M. Biotage AB has 64.71 M outstanding shares. BIOTAGE AB has accumulated about 19.02 M in cash with 18.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Check Biotage AB Probability Of Bankruptcy

Biotage AB Key Fundamentals

Biotage AB Against Markets

Biotage AB Current Ratings

Biotage AB 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Biotage AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation, and purification in the United States, Europe, Japan, China, and internationally. It sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage AB operates under Medical Instruments Supplies classification in USA and traded on OTC Market. It employs 7 people. more
NameBiotage AB
President and CEOTorben JoergensenView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressBox 8
ExchangeOTC Market
Phone46 18 56 59 00
CurrencyUSD - US Dollar

Biotage AB Directors

Biotage AB Corporate Directors

Karolina Lawitz Member of the Board of Directors
NilsOlof Bjork Director
Yvonne Martensson Director
Check also Trending Equities. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.